Top FDA drug official is trying to hire a friend who’s seeking a warning about unproven side effects of antidepressants

March 7, 2026 - 20:04

A senior official at the U.S. Food and Drug Administration is attempting to hire a personal friend and researcher who is pushing the agency to place new warnings on antidepressant medications. The proposed warnings would concern potential pregnancy-related side effects that are not scientifically proven.

The situation involves Dr. Tracy Beth Hoeg, the FDA's top drug regulator. Internal communications reveal Dr. Hoeg's efforts to bring the researcher onto the agency's staff. This researcher has been a prominent advocate for labeling that suggests a link between antidepressants and certain risks in pregnancy, a connection that major medical organizations and extensive studies have largely dismissed as unsubstantiated.

The move has raised immediate concerns about potential conflicts of interest and the integrity of the regulatory process. Critics argue that hiring a vocal proponent of a specific, unverified safety concern could improperly influence the FDA's neutral, science-based review of drug safety data. The agency is tasked with ensuring that drug labeling reflects rigorous, evidence-based findings to guide doctors and patients, making impartiality paramount.

An FDA spokesperson stated that the agency follows strict federal hiring rules and ethics regulations, but declined to comment on the specific personnel matter. The development underscores the delicate balance between expert advocacy and regulatory objectivity in public health policy.